Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPHS | AZN | AMGN | GILD | BMY |
| Company | Sophiris Bio | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0001 | 188.47 | 340.75 | 127.96 | 57.69 |
| High | 0.0001 | 190.00 | 349.54 | 132.21 | 60.78 |
| Low | 0.0001 | 186.87 | 340.05 | 127.96 | 57.39 |
| Latest | 0.0001 | 187.37 | 346.25 | 130.84 | 60.59 |
| Change | unch | +2.17 | +8.23 | +2.00 | +3.00 |
| % Change | unch | +1.17% | +2.43% | +1.55% | +5.21% |
| Volume | 1,000 | 2,797,400 | 3,592,000 | 6,660,200 | 24,880,100 |
| 20-Day Average Volume | 47,475 | 2,049,960 | 2,446,105 | 5,313,895 | 9,668,000 |
| Previous Close | 0.0001 | 185.20 | 338.02 | 128.84 | 57.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0047 | 197.68 | 346.94 | 135.97 | 58.82 |
| 20-Day Raw Stochastic | 0.00% | 22.06% | 49.04% | 20.87% | 94.66% |
| 20-Day Relative Strength | 35.47 | 41.84 | 46.93 | 39.71 | 55.45 |
| Weighted Alpha | -80.56 | +26.08 | +21.58 | +21.26 | +26.48 |
| Today's Opinion | 100% Sell | 40% Buy | 8% Buy | Hold | 72% Buy |
| Previous Opinion | 100% Sell | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 88% Sell | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -90.00% since 10/14/21 | -2.56% since 04/23/26 | -0.68% since 04/23/26 | -2.10% since 04/23/26 | +2.66% since 04/23/26 |
| Low | 0.0001 on 02/14/22 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 0.0001 on 02/14/22 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.32 on 04/24/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | unch since 12/30/21 | -3.36% since 03/30/26 | -0.79% since 03/30/26 | -4.03% since 03/30/26 | +1.44% since 03/30/26 |
| Low | 0.0001 on 02/14/22 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 0.0001 on 02/14/22 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | unch since 11/05/21 | +0.99% since 01/30/26 | +1.28% since 01/30/26 | -7.83% since 01/30/26 | +10.06% since 01/30/26 |
| Low | 0.0001 on 02/14/22 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 0.0001 on 02/14/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -99.29% since 08/13/21 | +13.78% since 10/30/25 | +18.58% since 10/30/25 | +10.47% since 10/30/25 | +32.81% since 10/30/25 |
| Low | 0.0001 on 02/14/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 45.20 on 10/31/25 |
| High | 0.0175 on 09/07/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4 | 287,228,128 | 182,424,320 | 159,919,040 | 117,583,520 |
| Shares Outstanding, K | 35,550 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -6,780,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | N/A | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 01/01/70 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.38 | 15.54 | 15.86 | 9.47 |